• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
+49 (0) 69 / 606 278 – 0
[email protected]
Contact form
Patent- & Rechtsanwaltskanzlei

Patent- & Rechtsanwaltskanzlei

  • Deutsch

+49 (0) 69 / 606 278 – 0

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • xing
  • Email
MENUMENU
  • Services
    • Advice On Protective IP Rights
    • Patent Application /TM Registration
    • Enforcement Of IP Rights
    • Defence Against IP Rights Enforcement
    • Costs
  • Company
    • Fields of Law
      • Patent Law
      • Utility Model Law
      • Employees’ Inventions
      • Trademark Law
      • Design Law
      • Trademark and Product Piracy
      • Expert Opinions
    • Our Law Firm
      • Dr. Karl-Hermann Meyer-Dulheuer
      • Dr. Tim Meyer-Dulheuer
      • Dr. Klaus Zimmermann
      • Zhichao Ying
      • Clara Elinor Grünewald
    • Commitment
  • Contact
    • Where To Find Us
    • Write us!
    • Request call back
  • Blog

EPA revokes Bayer’s biopatent on broccoli

20. November 2018

The European Patent Office (EPO) has revoked Bayer AG’s controversial Monsanto biopatent, which was intended to protect the breeding of broccoli to facilitate harvesting. It is the first revocation of a biopatent since the introduction of the newly revised EU regulation for biopatents in 2017.

Biopatent broccoliPatent EP 1 597 965, granted in 2013 to Monsanto, an agrochemical company acquired by Bayer in the meantime, covers broccoli plants that grow slightly higher and can therefore be harvested more easily. It has also become known as the “patent on decapitated broccoli. The revocation followed an objection raised by a coalition of organizations in 2014. Since an updated regulation in 2017, patents on plants and animals may no longer be granted if they result from common breeding methods such as crossing and selection.

Biopatent and the legal situation until 2017

In principle, the legal situation for biopatents is shaped by the European Patent Convention (EPC, Article 53, letter b), which was signed in 1973 – long before the genetic and biotechnological possibilities that exist today. Decisions were based on the EU Biopatent Directive (Directive 98/44/EC). However, in view of the fact that the EPO has already granted more than 1,000 biopatents, it has become increasingly urgent to adapt the legal requirements to modern technological methods.

With the question of how the EPC should be interpreted with regard to its regulations on the patentability of plants, the EPO’s Board of Appeal issued fundamental decisions in 2010 and 2015, in the so-called cases Broccoli I and Tomato I or Broccoli II and Tomato II. It stated that conventional breeding methods and marker-assisted selection may not be patented. However, plants and animals derived from such breeding should still be patentable as biopatents (decisions G02/12 and G02/13 (Broccoli II)). Technical process components used, such as a molecular marker, can also be patented as such.

Germany always regards the legal area of biopatents very sensitively and regarded the EU requirements as insufficient. In 2013 the German Patent Act was amended by 2a (1) No. 1 Patent Act. In contrast to the European patent, this clearly states that patents on plants and animals from conventional breeding are explicitly excluded.

2017 revised new EU regulation on biopatents

At the EU level, there were political negotiations to reach an EU-wide convergence in the assessment of biopatents. This led to the EPO’s revised regulation on biopatents in 2017 – we reported. If crossing and selection take place, patentability of the resulting plants and animals will also be excluded. Mutations, however, should remain patentable. In practical terms, this means that the broccoli patent of Plant Bioscience Limited, referred to as Broccoli II in the fundamental decision of 2015, would no longer be granted today. For this reason, European biopatents already granted since autumn 2017 are being re-examined. The deadline is November 2016: all biopatents granted by the EPO since November 2016 are reviewed by the EPO.

Patent protection through product-by-process claims

However, genetic engineering interventions are of course commonplace in plants and microorganisms. It is mainly technical selection procedures or product-by-process claims that provide patent protection.

A product-by-process claim is a characteristic of a product that is the subject of a claim, which is characterized by the characteristics of the process used to manufacture it.

It must be impossible to define the claimed product differently from its manufacturing process (e.g. starting materials or treatment processes). And, of course, the claimed product must meet patentability requirements.

In patent law, product-by-process claims are not easy to obtain. This is because § 9 sentence 2 no. 3 PatG already provides for direct product protection by law, even for a claim obtained through a process patent.

(Quoted and translated from IP Wikipedia www.legal-patent.com)

Biopatent on malting barley not revoked

Not surprisingly, a second prominent revocation procedure before the European Patent Office was decided at the beginning of October. The beer groups Heineken and Carlsberg were granted patent protection for conventionally bred malting barley by the European Patent Office (Patent EP 2384110). More than 30 environmental organisations appealed against the decision. In their opinion, a genetic predisposition was considered an invention in this patent, although it had arisen accidentally and the plants originated from conventional breeding. After a public hearing at the beginning of October, the controversial patent was restricted but not revoked.

The patent originally covered all plants lacking certain unwanted flavourings. “The patent description reads “FIRST WITH REDUCED LIPOXYGENASE ACTIVITY”. With its decision, the EPO now limited the patent to plants with certain mutations that can influence the formation of these flavors. Opposition to this decision has already been announced, so the proceedings against this patent are likely to continue.

This may also be interesting in this context:

  • ECJ ruling: Mutagenesis is among genetic engineering
  • Next step in Battle over CRISPR technology: EPO revokes important patent

 

Do you need support in patent protection for biotechnological, genetic or chemical processes?

We would be pleased to support you with the necessary research and correct registration of your trademark. Please take your chance and contact us.

Our lawyers are experienced in trademark and patent law, national and international law.

CAT-call_en

Sources:

EPO Register Revocation of Broccoli Patent

EPO Press release 2017: practice in the area of plant and animal patents

Opposition against barley patent

Picture:

jackmac34 /pixabay.com / CCO License  

  • share  
  • share 
  • share 
  • tweet  
  • share 

Category iconHealthcare & Lifesciences,  Patent Law Tag iconPatent,  Monsanto,  Biopatent,  biopatents,  Board of Appeal,  EPO,  plants,  revised regulation on biopatents,  barley,  genetic engineering,  patent on plants,  revocation,  Heineken,  Carlsberg,  Product-by-Process,  Bayer,  Germany

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

More articles about: Healthcare & Lifesciences

All articles

Blog Menu

  • Design Law
  • Healthcare & Lifesciences
  • International Intellectual Property
  • Licenses
  • News from our law firm
  • Overall
  • Patent Law
  • Product- and Trademark piracy
  • Trademark Law
This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

Recent Posts

  • Action against a patent already expired 26. February 2021
  • Design protection in China: Amendment 2021 25. February 2021
  • EPO practice of national patent offices – more uniform 18. February 2021
  • BGH: Black Forest ham – not only packaged in the Black Forest 16. February 2021

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Das könnte Sie auch interessieren:

26. February 2021
Action against a patent already expired

Action against a patent already expired

18. February 2021
EPO practice of national patent offices – more uniform

EPO practice of national patent offices – more uniform

15. February 2021
Employee’s invention in insolvency

Employee’s invention in insolvency

12. February 2021
Equivalence ruling of BGH: ‘Equivalent means’ in case Crane arm

Equivalence ruling of BGH: ‘Equivalent means’ in case Crane arm

5. February 2021
Trade secret: what are ‘appropriate’ secrecy measures?

Trade secret: what are ‘appropriate’ secrecy measures?

29. January 2021
Brexit: Changes for UK patent attorneys in GER

Brexit: Changes for UK patent attorneys in GER

Footer

Contact

Franklinstr. 61-63
D-60486 Frankfurt am Main
Germany

+49 (0) 69 / 606 278 – 0
+49 (0) 69 / 606 278 – 199
[email protected]

Customer Reviews

Meyer-Dulheuer MD Legal Patentanwälte PartG mbB Patentrecht, Markenrecht, Eigentum hat 4,78 von 5 Sternen 23 Bewertungen auf ProvenExpert.com

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Law Firm

  • Request non-binding call back
  • Info secure emails
  • Company
  • Our Law Firm
  • ISO Certificate
  • Privacy Policy
  • Data handling for clients
  • Imprint

Follow Us

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • xing
  • Email

Newsletter Signup

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

© Patent- & Rechtsanwaltskanzlei Meyer-Dulheuer MD Legal Patentanwälte PartG mbB

Kontaktformular

 

Rufen Sie uns an, schicken Sie uns eine Mail oder füllen Sie das Kontaktformular aus.

+49 (0) 69 / 606 278 – 0
[email protected]

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

Contact Form

 

Give us a call, send us an email or fill out the contact form.

+49 (0) 69 / 606 278 – 0
[email protected]

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form